Puma Biotechnology Inc (PBYI) earnings
PBYI earnings moved a median of +1.83% by the close. Quarterly and annual PBYI reports and results, each read against the price at its own news timestamp. Back to the PBYI overview →
25 measured PBYI earnings events.
Where these PBYI earnings landedvs 25 measured PBYI earnings reactions
| Middle 50% of PBYI earnings reactions | -1.29% to +12.38% |
|---|---|
| Median reaction (to close) | +1.83% |
| Measured reactions | 25 |
Point-in-time · zero look-ahead
Half of the 25 PBYI earnings events with a measured close landed between -1.29% and +12.38%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Jun 30 | SEC filing · Form 10-Q | +8.72% | +9.73% | |
| Puma Biotechnology Reports Second Quarter 2026 Financial Results | Press release | +8.72% | +9.73% | |
| Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results | Press release | -0.31% | -0.87% | |
| Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Mar 31 | SEC filing · Form 10-Q | +3.07% | +4.46% | |
| Puma Biotechnology Reports First Quarter 2026 Financial Results | Press release | +3.07% | +4.46% | |
| Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results | Press release | +0.00% | +1.75% | |
| Form 10-K PUMA BIOTECHNOLOGY, INC. For: Dec 31 | SEC filing · Form 10-K | +2.70% | -9.52% | |
| Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.38% | +12.38% | |
| Puma Biotechnology Reports Third Quarter 2025 Financial Results | Press release | -0.38% | +12.38% | |
| Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Jun 30 | SEC filing · Form 10-Q | +10.16% | +20.98% | |
| Form 10-Q/A PUMA BIOTECHNOLOGY, INC. For: Mar 31 | SEC filing · Form 10-Q | -1.22% | +0.00% | |
| Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results | Press release | -3.82% | -3.53% | |
| Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Mar 31 | SEC filing · Form 10-Q | +2.57% | -6.43% | |
| Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results | Press release | +0.00% | +1.01% | |
| Form 10-K PUMA BIOTECHNOLOGY, INC. For: Dec 31 | SEC filing · Form 10-K | +1.78% | +15.86% | |
| Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Sep 30 | SEC filing · Form 10-Q | -1.77% | -15.04% | |
| Puma Biotechnology Reports Third Quarter 2024 Financial Results | Press release | -1.77% | -15.04% | |
| Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.92% | +16.77% | |
| Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results | Press release | -0.54% | -1.08% | |
| Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.78% | -4.71% | |
| Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results | Press release | +2.44% | +1.83% | |
| Form 10-K PUMA BIOTECHNOLOGY, INC. For: Dec 31 | SEC filing · Form 10-K | +4.86% | +10.09% | |
| Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Sep 30 | SEC filing · Form 10-Q | +8.98% | +13.01% | |
| Puma Biotechnology Reports Third Quarter 2023 Financial Results | Press release | +8.98% | +13.01% | |
| Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2023 Financial Results | Press release | +0.00% | -1.29% |
Keep exploring
More PBYI: analyst actions → · SEC filings → · PBYI overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Evolus, Inc. (EOLS) | 275 | +0.08% | 51% |
| LivaNova PLC - Ordinary Shares (LIVN) | 275 | +0.04% | 51% |
| PRANA BIOTECH (PRAN) | 274 | 0.00% | 48% |
| Solana Company - Class A (HSDT) | 272 | -1.20% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.